Craft

Deva

Stock Price

₺68.2

2024-10-28

Market Capitalization

₺13.7 B

2024-10-28

Revenue

₺19.2 B

FY, 2025

Deva Summary

Company Summary

Overview
Deva manufactures and markets human pharmaceutical products. The Company's products include antineoplastic agents; dermatological products; antiparasitic products, insecticides, and repellents; sysyemic hormonal preparations; food supplements; and various other products, as well as electrolyte solutions. It also offers products in the areas of cardiovascular system, alimentary tract and metabolism, musculoskeletal system, nervous system, respiratory system. In addition, the Company produces and sells veterinary drugs, cologne, and medical ampoules, as well as raw materials.
Type
Public
Status
Active
Founded
1958
HQ
Istanbul, TR | view all locations
Website
http://www.deva.com.tr/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Philipp Haas

    Philipp Haas, Chairman & CEO

    • Mesut Çetin

      Mesut Çetin, Deputy Chairman of the BOD and CFO

      LocationsView all

      5 locations detected

      • Istanbul, İstanbul HQ

        Turkey

        Halkalı Merkez Mh., Basın Ekspres Cd. No:1

      • Kartepe, Kocaeli

        Turkey

        Ulus, Ankara Cd. No:2

      • Tekirdağ, Tekirdağ

        Turkey

        İsmet Paşa, OSB, Atatürk Cd. No:32

      • Tekirdağ, Tekirdağ

        Turkey

        İsmet Paşa, OSB, Fatih Bulvarý No:26

      • Tekirdağ, Tekirdağ

        Turkey

        Karaağaç Mah. 8. Sok. No:3 A

      Deva Financials

      Summary Financials

      Revenue (FY, 2025)
      ₺19.2B
      Gross profit (FY, 2025)
      ₺7.4B
      Net income (FY, 2025)
      (₺807.0M)
      Cash (FY, 2025)
      ₺2.4B
      EBIT (FY, 2025)
      ₺71.7M
      Enterprise value
      $17.3B

      Footer menu